News | Cardiac Resynchronization Therapy Devices (CRT) | Dave Fornell, Editor

May 15, 2019 — A pilot trial has shown His pacing in cardiac resynchronization therapy (CRT) has been shown to ...

Home May 15, 2019
Home
Technology | Ventricular Assist Devices (VAD)

The U.S. Food and Drug Administration (FDA) has approved the expansion of Abiomed’s Impella 5.0 and Impella LD premarket approval (PMA) labeling for the treatment of cardiogenic shock. The expansion extends the duration of support for each pump from 6 days to 14 days.

Home May 14, 2019
Home
News | Atrial Fibrillation | Dave Fornell, Editor

May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary vein ...

Home May 14, 2019
Home
News | Ablation Systems

The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus statement reflecting a worldwide updated review of the indications, techniques and outcomes of catheter ablation of ventricular arrhythmias (VAs). The expert consensus statement was presented at Heart Rhythm 2019, the HRS’s 40th Annual Scientific Sessions, May 8-11 in San Francisco.

Home May 14, 2019
Home
News | Cardiac Diagnostics

The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and management of arrhythmogenic cardiomyopathy (ACM), including findings on genetics and disease mechanisms. Recommendations included in the 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy were presented at Heart Rhythm 2019, the HRS’s 40th Annual Scientific Sessions, May 8-11 in San Francisco.

Home May 14, 2019
Home
News | EP Lab

May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs), such ...

Home May 14, 2019
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 13, 2019 — Boston Scientific announced acute results from the UNTOUCHED study evaluating safety and efficacy of the ...

Home May 13, 2019
Home
News | EP Lab

May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their ...

Home May 13, 2019
Home
News

May 13, 2019 – A first-in-human pilot study of Medtronic's investigational Extravascular Implantable Cardioverter ...

Home May 13, 2019
Home
News | Atrial Fibrillation

May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce atrial ...

Home May 13, 2019
Home
News | Atrial Fibrillation

May 13, 2019 — A digital screening for atrial fibrillation (AFib or AF) successfully monitored more than 60,000 ...

Home May 13, 2019
Home
News | Leads Implantable Devices

BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing.

Home May 13, 2019
Home
Technology | ECG

AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L the world's first available six-lead personal electrocardiogram (ECG) device, according to the company. This clearance gives patients and their physicians an even more detailed view into patients' hearts, including visibility into certain arrhythmias that are leading indicators of cardiovascular disease.

Home May 13, 2019
Home
News | Ablation Systems

Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a magnetic resonance imaging (MRI) ablation center for treating cardiac arrhythmias.

Home May 13, 2019
Home
AIMed conference in artificial intelligence in cardiology, medical imaging.
Feature | Artificial Intelligence

The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical ...

Home May 13, 2019
Home
Subscribe Now